GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pure Biologics PUR.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−PLN 9.8m

FY2016FY2025

Free cash flow

−PLN 6.3m

FY2016FY2025

Shareholders' equity

−PLN 14.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue——PLN 95,000PLN 662,000PLN 254,000PLN 572,000PLN 16.8mPLN 9.5mPLN 981,835PLN 1.3m
Research and developmentPLN 2.7mPLN 38,000PLN 8.2mPLN 23.8mPLN 20.6mPLN 18.4mPLN 14.9mPLN 4.6mPLN 3.1m—
Operating income−PLN 6.3m−PLN 12.4m−PLN 31.7m−PLN 24.6m−PLN 10.5m−PLN 11.6m−PLN 4.4m−PLN 631,019−PLN 386,248−PLN 419,454
Net income−PLN 9.8m−PLN 19.4m−PLN 35.7m−PLN 26.4m−PLN 13.1m−PLN 12.1m−PLN 4.7m−PLN 689,344−PLN 412,723−PLN 432,926
Diluted earnings per share-1.20-5.18-10.85-11.70-5.80-5.71-2.84-0.59-0.35-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 4.9mPLN 2.3mPLN 22.7mPLN 33.0mPLN 47.2mPLN 18.9mPLN 21.8mPLN 6.6mPLN 1.3mPLN 951,820
Cash and short-term investmentsPLN 10,000PLN 313,000PLN 3.6mPLN 7.2mPLN 32.9mPLN 9.0mPLN 13.9mPLN 195,935PLN 267,047PLN 219,519
Total liabilitiesPLN 19.1mPLN 15.5mPLN 20.8mPLN 14.7mPLN 7.7mPLN 21.8mPLN 14.6mPLN 4.4mPLN 1.1mPLN 640,124
DebtPLN 16.0mPLN 14.1mPLN 12.9mPLN 2.9mPLN 3.1mPLN 5.0mPLN 5.4mPLN 93,835PLN 154,997—
Shareholders' equity−PLN 14.1m−PLN 13.1mPLN 1.9mPLN 18.3mPLN 39.5m−PLN 2.9mPLN 7.2mPLN 2.2mPLN 209,773PLN 311,696
Shares outstanding8m4m3m2m2m2m2m1m1m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−PLN 6.3m−PLN 10.8m−PLN 23.3m−PLN 17.4m−PLN 24.0m−PLN 1.4mPLN 5.3m−PLN 2.5m−PLN 2.8m−PLN 710,244
Capital spending——−PLN 176,000−PLN 5.8m−PLN 673,000−PLN 561,000−PLN 161,916−PLN 162,152−PLN 162,152−PLN 441,499
Free cash flow−PLN 6.3m−PLN 10.8m−PLN 23.4m−PLN 23.1m−PLN 24.7m−PLN 1.9mPLN 5.2m−PLN 2.7m−PLN 3.0m−PLN 1.2m

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue———————−PLN 3,000
Operating income−PLN 1.7m−PLN 947,000−PLN 904,000−PLN 2.7m−PLN 800,000−PLN 6.9m−PLN 1.4mPLN 486,000
Net income−PLN 2.2m−PLN 2.5m−PLN 1.2m−PLN 4.7m−PLN 1.3m−PLN 10.7m−PLN 817,000−PLN 3.0m
Diluted earnings per share-0.19-0.31-0.15-0.58-0.16-2.84-0.22-0.80
Cash from operations−PLN 3.0m−PLN 5.0m———−PLN 3.0m−PLN 1.0m−PLN 7.0m
Total assetsPLN 1.6mPLN 4.9mPLN 1.3mPLN 1.9mPLN 2.3mPLN 2.3mPLN 10.8mPLN 11.4m
Cash and short-term investmentsPLN 1.0mPLN 10,000PLN 112,000PLN 295,000PLN 227,000PLN 313,000PLN 1.3mPLN 192,000
DebtPLN 14.4mPLN 15.9mPLN 15.0mPLN 14.6mPLN 14.3mPLN 14.1mPLN 13.7mPLN 13.4m
Shareholders' equity−PLN 16.4m−PLN 14.1m−PLN 19.4m−PLN 18.2m−PLN 13.5m−PLN 13.1m−PLN 5.0m−PLN 6.1m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-36.4%-11.3%—
Net income-28.1%-4.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-1.7-1.1-0.4-0.6-4.3-6.3-3.9-11.1
Price to sales——140.625.2221.9132.81.10.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.